Abstract Progression through G2 phase of the cell cycle is a technically difficult area of cell biology to study due to the lack of physical markers specific to this phase. The FUCCI system uses the biology of the cell cycle to drive fluorescence in select phases of the cell cycle. Similarly, a commercially available system has used a fluorescent analog of the Cyclin B1 protein to visualize cells from late S phase to the metaphaseanaphase transition. We have modified these systems to use the promoter and destruction box elements of Cyclin B1 to drive a cyan fluorescent protein. We demonstrate here that this is a useful tool for measuring the length of G2 phase without perturbing any aspect of cell cycle progression.
Introduction
Cell cycle progression is tightly regulated by a series of phosphorylation events driven by the cyclin dependent kinases (CDKs), which require specific binding to their regulatory cyclin partners. Kinasedependent control over the transition between G1 phase of the cell cycle into DNA synthesis (S phase) is heavily studied, however the events regulating the transition from G2 phase into mitosis (M phase) receive much less focus, especially in mammalian systems (Lim and Kaldis 2013) . The lack of tools to precisely measure movement through G2 phase of the cell cycle is one technical hurdle to studying this aspect of cell cycle control. Sakaue-Sawano et al. (2008) published the FUCCI reporter system for use in vitro and in vivo to measure the timing of G1 phase of the cell cycle and the relative timing in S/G2/M phase. This system relies on the cell cycle dependent oscillating activity of the E3 ligase complexes APC Cdh1 and SCF
Skp2
. Fluorescent analogs of Cdt1 and Geminin are used to detect cells in either G1 phase or S/G2/M phase of the cell cycle, respectively. This system is not able to measure the timing of movement through G2 phase directly.
A commercially available the G2/M Cell Cycle Phase Marker developed by Amersham Biosciences ] has come close to achieving this. This system expresses a large portion of the coding region of the G2/M cyclin, Cyclin B1, as well as the promoter from the Cyclin B1 gene (CCNB1). Cyclin B1 provides a valuable source for measuring the length of G2 phase of the cell cycle. Expression is first seen in late S-phase and the mRNA levels increase specifically during G2 phase (Pines and Hunter 1989; Piaggio et al. 1995) . It is known that using -3,800 bp relative to the cap site of the Cyclin B1 promoter can confer G2-enhanced promoter activity (Cogswell et al. 1995) . This system drives expression of the N-terminal domain of Cyclin B1 that includes a 9-amino-acid destruction box (D-box) motif (RTALGDIGN) that targets Cyclin B1 for ubiquitination and subsequent degradation (King et al. 1996a, b) . This D-box sequence is recognized by the APC Cdt ubiquitin system in metaphase and the protein is destroyed in anaphase of the cell cycle (Meyn et al. 2002; Passmore et al. 2003; Yamano et al. 2004) . Hence, this is a valuable tool for measuring the length of G2 up to the metaphase-anaphase transition. However, the Cyclin B1 region used in this system also includes the cytoplasmic retention sequence (CRS) domain of the protein, a region known to interact with a number of intracellular proteins (Fidalgo da Silva et al. 2011 Hagting et al. 1998; Barnes et al. 2001 ). This poses potential problems for researchers studying or manipulating these specific proteins as the reporter may interact with their proteins of interest and may cause unexpected side effects.
In this work we develop an analogous system that uses the Cyclin B1 promoter to drive a cyan fluorescent protein (ECFP) fused to a small D-box domain to ensure degradation at the metaphase-anaphase transition. Using live cell imaging in conjunction with Hoechst staining we demonstrate that this system does not alter the timing of G2 phase of the cell cycle or relative cell numbers as assessed using a metabolic marker.
Materials and methods

Construction of the G2/M CFP reporter
The pcDNA3-CFP plasmid obtained from Addgene (Cambridge, MA, USA; # 13030) was used as a backbone vector for the construction of the pCCNB1-ECFP G2/M reporter vector. The ECFP protein in the pcDNA3-CFP is expressed under the CMV promoter. The human cytomegalovirus (CMV) promoter drives constitutive protein expression in cells (Qin et al. 2010) . The CMV promoter was BglII-HindIII digested from the pcDNA3-CFP vector, and on its place a linker (BglII-GCACTTGCGGTGAGGCATAATTA-CAACT-HindIII) was used to close the resulting vector. The Cyclin B1 promoter was obtained from the pCycB(-3800)-CAT vector through HindIII-Bam-HI digestion (Cogswell et al. 1995) . The 2.75 kb promoter fragment was ligated into the pcDNA3-CFP without the CMV promoter. The sequence 5 0 -ATGAG AACCGCCCTGGGCGACATCGGCAACC-3 0 coding for the Cyclin B1 D-box sequence plus a 5 0 ATG starting codon was inserted into the new vector, between the promoter and the ECFP cassette, through BamHI and XhoI site.
Cell culture and transfection
Human Embryonic Kidney (HEK293) cells (ATCC, Manassas, VA, USA) were maintained in Dulbecco's Modified Eagle Medium (DMEM) (Sigma, St. Louis, MO, USA) supplemented with 1 % penicillin-streptomycin (PS) (Sigma) and 10 % fetal bovine serum (FBS) (Hyclone). Cells were incubated at 37°C in 5 % CO 2 . HEK293 cells were transfected with pcDNA3-ECFP or pCCNB1-ECFP using linear polyethylenimines (PEI) (Polysciences Inc., Warrington, PA, USA) (Reed et al. 2006 ) and incubated at 37°C 5 % CO 2 for 12-18 h after transfection.
Double thymidine block
Cells were arrested in S phase of the cell cycle with double thymidine block. HEK 293 cells were transfected and then incubated for *24 h. Medium was removed and replaced with fresh DMEM 10 % FBS 1 % PS per well. Cells were incubated overnight in medium containing 2 mM thymidine (Sigma-Aldrich). The next day, the medium was removed and the plates were washed with PBS. Fresh medium was added to the cells to release then from the S-phase arrest. After 8 h the 2 mM overnight thymidine block was repeated and followed by the PBS wash and addition of fresh media to release the cells from S-phase arrest.
Tetrazolium assay (MTT)
HEK 293 cells, transfected as described above, were split onto a 96-well plate. 20 ll of MTT (SigmaAldrich) stock (5 mg/ml in PBS) was added to each well and incubated at 37°C in 5 % CO 2 for 2 h. Then 100 ll of extraction buffer (20 % SDS in DMF/H 2 O, 2.5 % of 80 % acetic acid, 2.5 % 1 M HCl, pH 4.7) was added to each well overnight and incubated at 37°C in 5 % CO 2 . The absorbance of each well was taken at 570 nm.
Flow cytometry analysis HEK 293 cells were synchronized using double thymidine block, as described above and were carefully collected at indicated time-points. They were washed twice in PBS, and then either used immediately or fixed with 70 % ethanol for future analysis. Fresh or fixed cells were suspended in 1 ml of PBS and 50 ll of 500 lg/ml propidium iodide solution was added. A minimum of 300,000 cells were analyzed per treatment using a Beckman Coulter FC500 flowcytometer (Miami, FL, USA).
Immunofluorescence (IF) microscopy and quantification HEK 293 cells were seeded onto 10 cm plates containing glass cover-slips. Cells were cultured and transfected as described above. 24h following transfection the cells were arrested using double thymidine block. Cells were released and the cover-slips were collected at determined time points. The cells on the cover-slips were fixed with 4 % paraformaldehyde (PFA) in phosphate-buffered saline for 2 h and permeabilized with 0.02 % Triton X-100 for 5 min. TO-PRO-3-iodide (Invitrogen, Carlsbad, CA, USA) was used as nuclear stain. Cell images were obtained using LAS AF6000 software with a LEICA DMI6000 fluorescent microscope (Wetzlar, Germany). The total number of cells and ECFP fluorescent cells were counted using Metamorph AF 1.4 software. The percent of cells expressing ECFP or phosphor-histone H3 (pH3) was calculated by dividing the number of cell expressing ECFP or pH3 by the total cell number, as indicated by TO-PRO-3 (red cells) staining, and multiplying by 100. A minimum of 10 fields of view for each slide were counted for each experiment and the mean ± SD were calculated over an average of 3 individual experiments.
Statistical analysis
Data are presented as means ± the standard deviation. The statistical significance was determined by using Student t test (unpaired) through the http://www. physics.csbsju.edu/stats/t-test.html. p values B0.05 were considered significant and p values [0.05 were not considered significant.
Results and discussion
We have developed a new cell cycle fluorescent reporter to specifically measure the timing of cell movement through G2 phase of the cell cycle. This reporter can be used in state-steady experiments or during live-cell imaging. To create the new G2/M reporter, the CMV promoter cassette from pcDNA3-CFP was substituted by the Cyclin B1 promoter obtained from the pCycB (-3800)-CAT vector constructed by Dr. Cogswell (Cogswell et al. 1995) . Cogswell et al. (1995) GGCAAC) were inserted between the Cyclin B1 promoter and the ECFP through a BamHI-XhoI ligation, creating the new reporter vector pCCNB1-ECFP (Fig. 1) .
It was expected that the reporter would express ECFP fluorescent protein at the end of the S phase, fluorescence would peak during the G2/M transition and the signal would be degraded at the anaphase transition. To test this we transfected HEK 293 cells with pCCNB1-ECFP vector (G2/M reporter), arrested these cells in S-phase using double thymidine block (Bostock et al. 1971) . Cells were released from the block by removing the medium containing thymidine and adding fresh medium. The cells were fixed for IF at different time-points (0-8 h), and the ECFP fluorescence (Exc-434 nm, EM-477 nm) was detected using fluorescent microscopy. We observed that at 0 h approximately 5 % of fluorescence was detected and the cells were arrested in S phase. Fluorescence increases with time, reaching a peak at 4-6 h, and decreasing at 8 h after the thymidine block release (Fig. 2a) . We found that ECFP expression came on just prior to the phosphorylation of histone H3 (pH3; Fig. 2b indicated in green) . Hence the G2/M reporter comes on during G2 phase as one would expect and is degraded toward the end of mitosis. Flow Cytometry and MTT analysis were used to ensure that the region of the Cyclin B1 promoter (2.7 Kb) being used does not alter the G2/M cell cycle phase transition and cell proliferation. We arrested HEK293 cells using the double thymidine block, as above, and performed flow-cytometry analysis. As a control we used the pcDNA3-ECFP vector that contains the CMV promoter and constitutively drives ECFP in all phases of the cell cycle. According to our analysis approximately 50 % of the cells were in G2/ M transition at the time of the fluorescence peak (4-6 h), and no significant difference was observed when cells were transfected with the CMV or our G2/ M reporter (Fig. 3a) .
We also used the tetrazolium assay (MTT) (Mosmann 1983; Berridge et al. 2005) to measure the proliferation of HEK 293 cells transfected with the vectors above. We observed that there is no significant difference in the metabolic status of the cells transfected with the CMV promoter or the G2/M reporter construct (Fig. 3b) . We conclude that the pCCNB1-ECFP reporter is indeed expressing the ECFP protein under the control of the Cyclin B1 promoter and that the ECFP protein is being degraded after the G2/M transition. We see no adverse effects on the timing of M onset or on cell cycle phase or metabolic activity of the cells. 
